Literature DB >> 29650528

Practical guide to the meta-analysis of rare events.

Orestis Efthimiou1.   

Abstract

OBJECTIVE: Meta-analysing studies with low event rates is challenging as some of the standard methods for meta-analysis are not well suited to handle rare outcomes. This is more evident when some studies have zero events in one or both treatment groups. In this article, we discuss why rare events require special attention in meta-analysis, we present an overview of some approaches suitable for meta-analysing rare events and we provide practical recommendations for their use.
METHODS: We go through several models suggested in the literature for performing a rare events meta-analysis, highlighting their respective advantages and limitations. We illustrate these models using a published example from mental health. We provide the software code needed to perform all analyses in the appendix.
RESULTS: Different methods may give different results, and using a suboptimal approach may lead to erroneous conclusions. When data are very sparse, the choice between the available methods may have a large impact on the results. Methods that use the so-called continuity correction (eg, adding 0.5 to the number of events and non-events in studies with zero events in one treatment group) may lead to biased estimates.
CONCLUSIONS: Researchers should define the primary analysis a priori, in order to avoid selective reporting. A sensitivity analysis using a range of methods should be used to assess the robustness of results. Suboptimal methods such as using a continuity correction should be avoided. © Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29650528     DOI: 10.1136/eb-2018-102911

Source DB:  PubMed          Journal:  Evid Based Ment Health        ISSN: 1362-0347


  41 in total

1.  Transcranial direct current stimulation for unipolar depression and risk of treatment emergent mania: An updated meta-analysis.

Authors:  Yosef A Berlow; Amin Zandvakili; Linda L Carpenter; Noah S Philip
Journal:  Brain Stimul       Date:  2019-03-18       Impact factor: 8.955

2.  Efficacy and Safety of Ibuprofen Plus Paracetamol in a Fixed-Dose Combination for Acute Postoperative Pain in Adults: Meta-Analysis and a Trial Sequential Analysis.

Authors:  Dina Abushanab; Daoud Al-Badriyeh
Journal:  CNS Drugs       Date:  2021-01-11       Impact factor: 5.749

3.  Lack of association between TREM2 rs75932628 variant and amyotrophic lateral sclerosis.

Authors:  Vasileios Siokas; Athina-Maria Aloizou; Ioannis Liampas; Zisis Tsouris; Alexios-Fotios A Mentis; Grigorios Nasios; Dimitra Papadimitriou; Dimitrios P Bogdanos; Georgios M Hadjigeorgiou; Efthimios Dardiotis
Journal:  Mol Biol Rep       Date:  2021-04-07       Impact factor: 2.316

4.  Meta-analysis of rare adverse events in randomized clinical trials: Bayesian and frequentist methods.

Authors:  Hwanhee Hong; Chenguang Wang; Gary L Rosner
Journal:  Clin Trials       Date:  2020-12-01       Impact factor: 2.486

Review 5.  Application of non-negative matrix factorization in oncology: one approach for establishing precision medicine.

Authors:  Ryuji Hamamoto; Ken Takasawa; Hidenori Machino; Kazuma Kobayashi; Satoshi Takahashi; Amina Bolatkan; Norio Shinkai; Akira Sakai; Rina Aoyama; Masayoshi Yamada; Ken Asada; Masaaki Komatsu; Koji Okamoto; Hirokazu Kameoka; Syuzo Kaneko
Journal:  Brief Bioinform       Date:  2022-07-18       Impact factor: 13.994

6.  Light Therapy for Patients With Bipolar Depression: Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Authors:  Raymond W Lam; Minnie Y Teng; Young-Eun Jung; Vanessa C Evans; John F Gottlieb; Trisha Chakrabarty; Erin E Michalak; Jill K Murphy; Lakshmi N Yatham; Dorothy K Sit
Journal:  Can J Psychiatry       Date:  2019-12-12       Impact factor: 4.356

7.  Evaluating the cardiovascular safety of sclerostin inhibition using evidence from meta-analysis of clinical trials and human genetics.

Authors:  Jonas Bovijn; Kristi Krebs; Chia-Yen Chen; Ruth Boxall; Jenny C Censin; Teresa Ferreira; Sara L Pulit; Craig A Glastonbury; Samantha Laber; Iona Y Millwood; Kuang Lin; Liming Li; Zhengming Chen; Lili Milani; George Davey Smith; Robin G Walters; Reedik Mägi; Benjamin M Neale; Cecilia M Lindgren; Michael V Holmes
Journal:  Sci Transl Med       Date:  2020-06-24       Impact factor: 17.956

8.  Ivermectin for Prevention and Treatment of COVID-19 Infection: A Systematic Review, Meta-analysis, and Trial Sequential Analysis to Inform Clinical Guidelines.

Authors:  Andrew Bryant; Theresa A Lawrie; Therese Dowswell; Edmund J Fordham; Scott Mitchell; Sarah R Hill; Tony C Tham
Journal:  Am J Ther       Date:  2021-06-21       Impact factor: 2.688

9.  Frequency of severe reactions following penicillin drug provocation tests: A Bayesian meta-analysis.

Authors:  António Cardoso-Fernandes; Kimberly G Blumenthal; Anca Mirela Chiriac; Isabel Tarrio; David Afonso-João; Luís Delgado; João Almeida Fonseca; Luís Filipe Azevedo; Bernardo Sousa-Pinto
Journal:  Clin Transl Allergy       Date:  2021-06       Impact factor: 5.871

10.  Utilization of the evidence from studies with no events in meta-analyses of adverse events: an empirical investigation.

Authors:  Chang Xu; Xiaoqin Zhou; Liliane Zorzela; Ke Ju; Luis Furuya-Kanamori; Lifeng Lin; Cuncun Lu; Omran A H Musa; Sunita Vohra
Journal:  BMC Med       Date:  2021-06-15       Impact factor: 8.775

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.